215 related articles for article (PubMed ID: 30157096)
1. Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
Ishii H; Hirai K; Sugiyama K; Nakatani E; Kimura M; Itoh K
Ther Drug Monit; 2018 Dec; 40(6):693-698. PubMed ID: 30157096
[TBL] [Abstract][Full Text] [Related]
2. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
Hirai K; Ishii H; Shimoshikiryo T; Shimomura T; Tsuji D; Inoue K; Kadoiri T; Itoh K
Ther Drug Monit; 2016 Dec; 38(6):706-710. PubMed ID: 27681114
[TBL] [Abstract][Full Text] [Related]
3. Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.
Hirai K; Ihara S; Kinae A; Ikegaya K; Suzuki M; Hirano K; Itoh K
Ther Drug Monit; 2016 Jun; 38(3):393-7. PubMed ID: 27172381
[TBL] [Abstract][Full Text] [Related]
4. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
[TBL] [Abstract][Full Text] [Related]
8. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
[TBL] [Abstract][Full Text] [Related]
9. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
Elyasi S; Khalili H
Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study.
Oda K; Katanoda T; Hashiguchi Y; Kondo S; Narita Y; Iwamura K; Nosaka K; Jono H; Saito H
J Infect Chemother; 2020 May; 26(5):444-450. PubMed ID: 31879186
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance.
Molina KC; Hall ST; Barletta JF; Mangram AJ; Dzandu JK; Huang V
Surg Infect (Larchmt); 2020 Feb; 21(1):43-47. PubMed ID: 31335259
[No Abstract] [Full Text] [Related]
15. Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
Okada N; Chuma M; Azuma M; Nakamura S; Miki H; Hamano H; Goda M; Takechi K; Zamami Y; Abe M; Ishizawa K
Eur J Clin Pharmacol; 2019 Dec; 75(12):1695-1704. PubMed ID: 31511938
[TBL] [Abstract][Full Text] [Related]
16. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
Qian X; Du G; Weng C; Zhou H; Zhou X
Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
[TBL] [Abstract][Full Text] [Related]
18. [The effect of renal clearance on serum trough concentration of vancomycin in elderly patients with severe pneumonia].
Zhou QT; He B; Shen N; Sun LN
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):105-9. PubMed ID: 26879613
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
[TBL] [Abstract][Full Text] [Related]
20. Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance.
Chu Y; Luo Y; Qu L; Zhao C; Jiang M
Pharm Biol; 2016 Dec; 54(12):2802-2806. PubMed ID: 27251880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
